Page last updated: 2024-09-05

solifenacin succinate and Urinary Tract Infections

solifenacin succinate has been researched along with Urinary Tract Infections in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Islianti, PI; Matondang, FA; Rahardjo, HE; Syahputra, FA1
Walton, A1
Brubaker, L; Khandwala, S; Lowder, J; Meikle, SF; Menefee, SA; Nolen, TL; Nygaard, I; Paraiso, MF; Richter, HE; Schaffer, J; Sirls, L; Spino, C; Visco, AG; Wallace, D1

Trials

2 trial(s) available for solifenacin succinate and Urinary Tract Infections

ArticleYear
Efficacy of Additional Solifenacin Succinate Therapy for Storage Symptoms in Females with Uncomplicated Lower Urinary Tract Infection: The SOLUTION Randomized Controlled Trial.
    Acta medica Indonesiana, 2018, Volume: 50, Issue:3

    Topics: Adult; Double-Blind Method; Female; Humans; Middle Aged; Muscarinic Antagonists; Quality of Life; Solifenacin Succinate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Tract Infections

2018
Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence.
    The New England journal of medicine, 2012, Nov-08, Volume: 367, Issue:19

    Topics: Aged; Benzilates; Botulinum Toxins, Type A; Cholinergic Antagonists; Double-Blind Method; Female; Humans; Intention to Treat Analysis; Linear Models; Middle Aged; Nortropanes; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Incontinence, Urge; Urinary Retention; Urinary Tract Infections; Xerostomia

2012

Other Studies

1 other study(ies) available for solifenacin succinate and Urinary Tract Infections

ArticleYear
Managing overactive bladder symptoms in a palliative care setting.
    Journal of palliative medicine, 2014, Volume: 17, Issue:1

    Topics: Aged, 80 and over; Butylscopolammonium Bromide; Cholinergic Antagonists; Humans; Incontinence Pads; Male; Muscarinic Antagonists; Palliative Care; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder Neoplasms; Urinary Bladder, Overactive; Urinary Tract Infections

2014